BioSig Technologies, Inc. & Streamex Announce Closing of $15 Million Public Offering

Core Viewpoint - BioSig Technologies, Inc. has successfully closed an underwritten public offering to support its merger with Streamex Exchange Corporation, focusing on gold tokenization infrastructure [1][2][3]. Group 1: Offering Details - The offering included 3,852,149 shares of common stock priced at $3.90 per share, generating gross proceeds of approximately $15,023,381 before expenses [2]. - The net proceeds will be utilized for purchasing gold bullion, general corporate purposes, and working capital [2]. Group 2: Strategic Intent - The CEO of BioSig emphasized the importance of aligning short and long-term capital strategies with high-quality shareholders to enhance shareholder value [3]. - The company aims to establish itself as a leader in the gold bullion-based real-world asset space, leveraging the recent capital raise [3]. Group 3: Company Background - Streamex is focused on building institutional-grade infrastructure for gold tokenization, supported by a gold-denominated treasury [6]. - BioSig Technologies is a medical device company known for its PURE EP™ Platform, which aids electrophysiologists in treating cardiovascular arrhythmias [7][8].